113 related articles for article (PubMed ID: 15736165)
1. TGF-beta induces novel Lef-1 splice variants through a Smad-independent signaling pathway.
Cordray P; Satterwhite DJ
Dev Dyn; 2005 Apr; 232(4):969-78. PubMed ID: 15736165
[TBL] [Abstract][Full Text] [Related]
2. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
[TBL] [Abstract][Full Text] [Related]
3. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
Asally M; Yoneda Y
Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755
[TBL] [Abstract][Full Text] [Related]
4. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
5. Dynamic expression of Lef/Tcf family members and beta-catenin during chick gastrulation, neurulation, and early limb development.
Schmidt M; Patterson M; Farrell E; Münsterberg A
Dev Dyn; 2004 Mar; 229(3):703-7. PubMed ID: 14991726
[TBL] [Abstract][Full Text] [Related]
6. A novel isoform of human lymphoid enhancer-binding factor-1 (LEF-1) gene transcript encodes a protein devoid of HMG domain and nuclear localization signal.
Kobielak A; Kobielak K; Trzeciak WH
Acta Biochim Pol; 2001; 48(1):221-6. PubMed ID: 11440173
[TBL] [Abstract][Full Text] [Related]
7. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
Jung HC; Kim K
Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation.
Daniels DL; Weis WI
Nat Struct Mol Biol; 2005 Apr; 12(4):364-71. PubMed ID: 15768032
[TBL] [Abstract][Full Text] [Related]
9. Beta-catenin/LEF-1 signalling in breast cancer--central players activated by a plethora of inputs.
Gebeshuber CA; Sladecek S; Grunert S
Cells Tissues Organs; 2007; 185(1-3):51-60. PubMed ID: 17587808
[TBL] [Abstract][Full Text] [Related]
10. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
Halder SK; Beauchamp RD; Datta PK
Exp Cell Res; 2005 Jul; 307(1):231-46. PubMed ID: 15922743
[TBL] [Abstract][Full Text] [Related]
11. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor.
Dong YF; Soung do Y; Schwarz EM; O'Keefe RJ; Drissi H
J Cell Physiol; 2006 Jul; 208(1):77-86. PubMed ID: 16575901
[TBL] [Abstract][Full Text] [Related]
12. Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(beta) in mesenchymal chondroprogenitor cell growth.
O'Rear L; Longobardi L; Torello M; Law BK; Moses HL; Chiarelli F; Spagnoli A
J Mol Endocrinol; 2005 Jun; 34(3):723-37. PubMed ID: 15956343
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cell growth by TGF beta 1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells.
Satterwhite DJ; Aakre ME; Gorska AE; Moses HL
Cell Growth Differ; 1994 Aug; 5(8):789-99. PubMed ID: 7986745
[TBL] [Abstract][Full Text] [Related]
14. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
[TBL] [Abstract][Full Text] [Related]
15. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
Edmiston JS; Yeudall WA; Chung TD; Lebman DA
Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP.
Cui Q; Lim SK; Zhao B; Hoffmann FM
Oncogene; 2005 Jun; 24(24):3864-74. PubMed ID: 15750622
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor HNF-6/OC-1 inhibits the stimulation of the HNF-3alpha/Foxa1 gene by TGF-beta in mouse liver.
Plumb-Rudewiez N; Clotman F; Strick-Marchand H; Pierreux CE; Weiss MC; Rousseau GG; Lemaigre FP
Hepatology; 2004 Dec; 40(6):1266-74. PubMed ID: 15562441
[TBL] [Abstract][Full Text] [Related]
18. Mapping canonical Wnt signaling in the developing and adult retina.
Liu H; Thurig S; Mohamed O; Dufort D; Wallace VA
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5088-97. PubMed ID: 17065530
[TBL] [Abstract][Full Text] [Related]
19. Wnt-3a regulates chondrocyte differentiation via c-Jun/AP-1 pathway.
Hwang SG; Yu SS; Lee SW; Chun JS
FEBS Lett; 2005 Aug; 579(21):4837-42. PubMed ID: 16099458
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling.
Seo T; Park J; Choe J
Cancer Res; 2005 Mar; 65(5):1738-47. PubMed ID: 15753369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]